News

Announcement

Horizon Scanning in Oncology – Prioritisation of new and emerging oncologic drugs

Within the project Horizon Scanning in Oncology 9 databases are frequently scanned to identify new/emerging oncologic drugs. Every 3 months, these drugs are filtered according to predefined criteria (i.e. in most instances availability of phase III study results) and are then prioritised by an expert panel to identify those therapies for which either a substantial clinical or financial impact can be expected.

HSO Prioritisation No. 19

More...

Announcement

Evaluation of individual medical procedures 2014 - Reports

We are pleased to introduce our new reports.

Decision Support Documents 2014:

• DSD 74: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy of peritoneal carcinomatosis
  https://eprints.aihta.at/1031
• DSD 75: Drug eluting stents for the treatment of peripheral artery disease
  https://eprints.aihta.at/1032
• DSD 76: Stereotactic  Radiofrequency ablation/ SRFA for hepatocellular carcinoma and liver metastases
  https://eprints.aihta.at/1030

+2 Updates:

• DSD 20/ Update 2014: Implantation of endobronchial valves in patients with emphysema
  https://eprints.aihta.at/1028
• DSD 44/1. Update 2014: Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation (1st Update 2014)
  https://eprints.aihta.at/1029

More...

Announcement

Horizon Scanning in Onkology - Reports

We are pleased to introduce our new HSO report.

DSD HSO No. 45
Obinutuzumab (Gazyva®) for previously untreated patients with chronic lymphocytic leukaemia (CLL)

More...

Newsletter Archive

Newsletter Juni 2014 | Nr. 128

• Alemtuzumab/Lemtrada® bei Multipler Sklerose
• Therapie am Lebensende bei fortgeschrittenem Karzinom
• Komplexe Interventionen
• Assessment – APPRAISAL – Decision
• Personalisierte Medizin/PM

More...

Project /

Acupuncture - areas of application, current evidence and proven indications

Duration: April 2014 - November 2014
Publication: LBI-HTA Project report No. 78: https://eprints.aihta.at/1042/

More...

Project /

Vasoprotectives: Efficacy and safety of capillary stabilising agents for venous insufficiency or haemorrhoids

Duration: May 2014 – December 2014
Publication: LBI-HTA Project report. 79:https://eprints.aihta.at/1047/

More...

Project /

Opportunities and strategies to drive appropriate use of MRI in Austria

Duration:  April 2014 – November 2014
Publication: HTA Projektbericht Nr. 80: https://eprints.aihta.at/1043/

More...

Newsletter Archive

Newsletter May 2014 | Nr. 127

• "Recovery" bei psychischen Erkrankungen – Das Ende der Unheilbarkeit: eine Lebenshaltung
• Horizon Scanning in der Onkologie – Priorisierung onkologischer Wirkstoffe
• Qualitätsindikatoren in der Onkologie
• Yoga bei diversen Indikationen
• Stationäre psychiatrische Rehabilitation – Nachhaltigkeit oder Kurzzeiteffekt

More...

Article

Horizon Scanning in Oncology – Prioritisation of new and emerging oncologic drugs

More...

Announcement

Sustainability of inpatient psychiatric rehabilitation for adults: systematic review

Against the backdrop of an increase in disability pensions due to mental health disorders, the aim of this review was a systematic analysis of the sustainability of inpatient psychiatric/ psychosomatic rehabilitation covering an observation period of at least 12 months after discharge from rehabilitation.

Overall, included studies (1 meta-analysis, 4 RCTs, 2 pre-post studies with, and 14 without a control group) showed similar trends: the improvement between admission and discharge deteriorated to varying degrees during the catamnestic period. Nevertheless, results remained better than at admission, though. In studies on specific aftercare we observed a trend towards an improved stabilization of treatment effects.

Publication: LBI-HTA Project report No.75: https://eprints.aihta.at/1025

Contact: Brigitte Piso

More...